A Study of TPD3310 in Patients With Advanced Malignant Tumors
Clinical trial NCT07368127 · RECRUITING
Trial details
- NCT number
- NCT07368127
- Sponsor
- TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2028-03-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.